The realm of biotechnology is constantly evolving, and at the forefront of this revolution stands advanced peptide synthesis. These small protein fragments hold immense opportunity for revolutionizing healthcare. Medical Professionals are utilizing the power of engineered peptides to create novel

Eli Lilly and Company has taken the lead in in the development and tirzepatide, a groundbreaking drug for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, exhibits significant ability to improve glycemic control and reduce the risk of cardiovascular disease. The complex manufa